• Home
• Healthcare
• News Article

Ground-breaking medical device measuring cell damage to be launched in MENA

Mena region to be part of a global medical technology revolution, as Revelar system will be rolled out in the UAE in April.
Believe it or not, but it is now possible to diagnose in real time if you are ill or not by breathing into a tube. US-based Pulse Health's Revelar system is a new milestone in medical technology, as it is able to diagnose a person's wellness or illness by tracking aldehydes, or organic compounds released when cell damage occurs in a body.

Revelar is a breakthrough breath technology that accurately detects and measures the presence of aldehydes, which are indicators of free radical damage in a body. The Revelar system measures volatile and often toxic aldehydes that exit a body through exhaled breath. The non-invasive technology uses a Revelar Breath Tube to capture these aldehydes in a unique manner, and come up with a Revelar Score, which reflects breath aldehydes in the parts-per-billion range. The device is simple to use, and takes less than seven minutes to get a personal score, which helps to detect oxidative stress in the human body.

This ground breaking new medical technology is now set to be introduced in the Middle East and North Africa region for the first time, beginning April this year, by Pharmaplus, which is the regional distributor for this device.

Mr. Alaa Altaher, CEO of Pharmaplus, said: "Aldehydes are evidence of cellular injury, and many are also highly toxic themselves. The Revelar score is a measurement tool to give patients a very specific method to measure aldehydes, help reduce free radical damage and ultimately improve health. If a doctor has this data in his hand, then he will be able to prescribe appropriate antioxidants and enzymes, or give stress reduction advice and suggest appropriate exercises to alter the score and help in improving the wellness of a patient."

The Revelar device is currently in the registration process with the UAE Ministry of Health. Mr. Alaa Altaher said that the device is being registered in the Grade 1 category. He also added that the device will be rolled out in phases in the UAE and the region.

"We will roll out Revelar to the hospitals first, and then target corporates and insurance companies," he said.

Pulse Health, the owners of the Revelar device, is in the process of launching other medical devices that use breath-analyzers. The company is planning global launch of two devices shortly, one that will measure cholesterol and another that would measure blood pressure, both using breath technology.

-Ends-

About Pharmaplus:
Pharmaplus was incorporated in 1995 in the UAE. Pharmaplus has made a mark of its own in the pharmaceutical distribution business (Vitamins & Food Supplements) in the Middle East.

Thinkprevention is a group of Medical Doctors across Europe and the US. The aim of the organisation is to promote preventative healthcare and help people for Wellness and Longevity. Thinkprevention holds the marketing rights of Revelar for the Entire Europe & MENA region. They have appointed Pharmaplus to promote the product in the MENA Region.

About Pulse Health
Pulse Health was established in 2006 to deliver breakthrough breath technologies that can better identify health risks through the superior measurement of key biomarkers. Pulse Health has a science advisory board of nine physicians and scientists from around the world, representing the leaders in exhaled breath diagnostics, pulmonary disease, immunology, nutrition and biopharmaceuticals. Pulse Health's Revelar is the first non-invasive device that measures aldeyhydes, known indicators of free radical damage. Revelar helps healthcare professionals test for damage caused by aldehydes and provides people insight to better impact their health and wellness. For more information, please log in to www.myrevelar.com

Contact Details:
Mr. Deepak Jaswal
deepak@pharmaplusltd.com
Mobile : +97150-4539861

© Press Release 2012